Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum.
JACC. Heart failure（2023）
摘要
The relative benefits of dapagliflozin were consistent in Black and White patients across the range of left ventricular ejection fraction, with greater absolute benefits in Black patients. (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure [DAPA-HF]; NCT03036124; Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure [DELIVER]; NCT03619213).
更多查看译文
关键词
Black race,clinical trial,heart failure,outcomes,race,sodium-glucose cotransporter 2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要